Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of pediatric bosentan in children with pulmonary arterial hypertension (FUTURE 5 extension)
2011-004612-31Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started May 2012; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2011-004612-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004612-31.